Literature DB >> 6152262

Neuropeptides in dopamine-containing regions of the brain.

A Albanese, M C Altavista.   

Abstract

This paper reviews evidence of direct interactions occurring in the central nervous system between peptide- and dopamine-containing neural networks. While it seems fairly clear that neuropeptides are involved in the process of interneuronal communication, their specific role appears to be different from that of classic transmitters (which include dopamine). Neuropeptides coexist with dopamine in specific dopamine-containing neurons; in addition they interact abundantly with the dopaminergic neurons, by acting either on the perikarya or on the dopaminergic nerve terminals. Such interactions are reciprocal and account for some behavioral correlates of neuropeptide and dopamine alterations in the brain. They also shed new light on the pathophysiology of neurological and psychiatric diseases associated with depletion or abundance of brain peptides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152262     DOI: 10.1007/BF02042622

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  151 in total

1.  Increased spontaneous activity following substance P infusion into A10 dopaminergic area.

Authors:  L Stinus; A E Kelley; S D Iversen
Journal:  Nature       Date:  1978-12-07       Impact factor: 49.962

2.  Distribution of somatostatin in the frog brain, Rana catesbiana, in relation to location of catecholamine-containing neuron system.

Authors:  S Inagaki; S Shiosaka; K Takatsuki; M Sakanaka; H Takagi; E Senba; T Matsuzaki; M Tohyama
Journal:  J Comp Neurol       Date:  1981-10-10       Impact factor: 3.215

3.  Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophyses: immunoreactive methionine-enkephalin-, leucine-enkephalin- and cholecystokinin-like substances.

Authors:  R Martin; R Geis; R Holl; M Schäfer; K H Voigt
Journal:  Neuroscience       Date:  1983       Impact factor: 3.590

4.  Distribution and concentration of TRH in the rat brain.

Authors:  C Oliver; R L Eskay; N Ben-Jonathan; J C Porter
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

5.  Substance P release from the rat substantia nigra.

Authors:  T M Jessell
Journal:  Brain Res       Date:  1978-08-11       Impact factor: 3.252

6.  Indication of an antipsychotic action of the opiate antagonist naloxone.

Authors:  H M Emrich; C Cording; S Pirée; A Kölling; D von Zerssen; A Herz
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1977-09

7.  Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality.

Authors:  E Dupont; S E Christensen; A P Hansen; B de Fine Olivarius; H Orskov
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

8.  Increased CSF levels of endorphines in chronic psychosis.

Authors:  L Terenius; A Wahlström; L Lindström; E Widerlöv
Journal:  Neurosci Lett       Date:  1976-10       Impact factor: 3.046

9.  Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE).

Authors:  W M Verhoeven; H M van Praag; J M van Ree; D de Wied
Journal:  Arch Gen Psychiatry       Date:  1979-03

Review 10.  Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.

Authors:  R M Post; P Gold; D R Rubinow; J C Ballenger; W E Bunney; F K Goodwin
Journal:  Life Sci       Date:  1982-07-05       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.